Comparison

DMU-212 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 5 mg
Item no. HY-137977-5mg
CASRN 134029-62-2
eClass 6.1 30220300
eClass 9.0 32160605
Available
Purity 99.74
Product Description
DMU-212 is a methylated derivative of Resveratrol (HY-16561), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212 has orally active[1][2].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
300.35
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 20 mg/mL (ultrasonic)
Manufacturers Target
Apoptosis; ERK
Pathway
Apoptosis; MAPK/ERK Pathway; Stem Cell/Wnt
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close